Addenda Capital Inc. reduced its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,224 shares of the company’s stock after selling 968 shares during the period. Addenda Capital Inc.’s holdings in Colgate-Palmolive were worth $1,647,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of CL. American Beacon Advisors Inc. purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $102,000. Proficio Capital Partners LLC lifted its position in Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora purchased a new position in Colgate-Palmolive during the 2nd quarter valued at about $109,000. Harbour Capital Advisors LLC purchased a new position in Colgate-Palmolive during the 1st quarter valued at about $121,000. Finally, Hanson & Doremus Investment Management lifted its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the period. 73.09% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Addenda Capital Inc. Sells 968 Shares of Colgate-Palmolive Company (CL)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/20/addenda-capital-inc-sells-968-shares-of-colgate-palmolive-company-cl.html.

A number of research analysts recently issued reports on CL shares. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, July 4th. Morgan Stanley raised shares of Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $75.00 to $84.00 in a research report on Monday, September 25th. Jefferies Group LLC lifted their price target on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research report on Thursday, July 6th. BidaskClub cut shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research report on Wednesday, July 12th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $76.85.

Colgate-Palmolive Company (NYSE CL) opened at 73.14 on Friday. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a market capitalization of $64.42 billion, a PE ratio of 27.18 and a beta of 0.81. The stock’s 50 day moving average is $72.81 and its 200 day moving average is $73.23.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s revenue was down .5% on a year-over-year basis. During the same period last year, the firm posted $0.70 EPS. Equities analysts anticipate that Colgate-Palmolive Company will post $2.90 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 59.48%.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the completion of the transaction, the insider now directly owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total transaction of $999,040.00. Following the transaction, the senior vice president now directly owns 88,598 shares of the company’s stock, valued at $6,322,353.28. The disclosure for this sale can be found here. Insiders have sold a total of 214,136 shares of company stock valued at $15,416,385 over the last three months. 1.02% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.